Taiwan permanently bans weight loss drug Belviq
Taipei, July 16 (CNA) The drug permit license for the weight loss drug Belviq has been permanently revoked in Taiwan, the country's Food and Drug Administration (FDA) said Thursday, citing cancer risks.
(Full text of the story is now in CNA English news archive. To view the full story, you will need to be a subscribed member of the CNA archive. To subscribe, please read here.)
Taiwan shares rebound, end above 17,200 points05/07/2021 04:53 PM
U.S., Taiwan, Paraguay eye cooperation in renewable energy05/07/2021 04:41 PM
U.S. dollar closes lower on Taipei forex market05/07/2021 04:15 PM
3 more referendum proposals meet signature requirements05/07/2021 04:07 PM
Taiwan reports 5 new imported COVID-19 cases05/07/2021 03:43 PM